Form 8-K - Current report:
SEC Accession No. 0001193125-26-326785
Filing Date
2026-07-31
Accepted
2026-07-31 07:23:30
Documents
19
Period of Report
2026-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d253972d8k.htm   iXBRL 8-K 37455
2 EX-1.1 d253972dex11.htm EX-1.1 202606
3 EX-4.1 d253972dex41.htm EX-4.1 76932
4 EX-4.2 d253972dex42.htm EX-4.2 86309
5 EX-5.1 d253972dex51.htm EX-5.1 15325
6 EX-99.1 d253972dex991.htm EX-99.1 7400
7 EX-99.2 d253972dex992.htm EX-99.2 7906
11 GRAPHIC g253972g0731102331943.jpg GRAPHIC 3465
12 GRAPHIC g253972g73y31.jpg GRAPHIC 6588
  Complete submission text file 0001193125-26-326785.txt   684129

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ino-20260729.xsd EX-101.SCH 3159
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20260729_lab.xml EX-101.LAB 17992
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20260729_pre.xml EX-101.PRE 11248
22 EXTRACTED XBRL INSTANCE DOCUMENT d253972d8k_htm.xml XML 3642
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 261225419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)